The combined use of human menopausal gonadotropin and Parlodel (bromocriptine) for in vitro fertilization
Margalioth, E.J.; Navot, D.; Rabinowitz, R.; Laufer, N.; Lewin, A.; Schenker, J.G.
International Journal of Fertility 31(4): 278; 282-283
1986
ISSN/ISBN: 0020-725X PMID: 2878897 Document Number: 282187
A successful pregnancy resulting from in vitro fertilization and embryo transfer in which bromocriptine was utilized for ovulation induction is reported. Suppression of transient hyperprolactinemia during induction of ovulation is suggested.
Document emailed within 1 workday
Related Documents
Yang, T.S.; Wang, B.C.; Chang, S.P.; Ng, H.T. 1995: Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization Zhonghua Yi Xue Za Zhi 55(6): 452-456Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Toth, T.L.; Awwad, J.T.; Veeck, L.L.; Jones, H.W.; Muasher, S.J. 1996: Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program Journal of Reproductive Medicine 41(5): 321-326
Molo, M.W.; Rawlins, R.G.; Binor, Z.; Kelly, M.; Radwanska, E. 1995: Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles Journal of Reproductive Medicine 40(6): 418-422
Fulghesu, A.M.; Lanzone, A.; Guida, C.; Nicoletti, M.C.; Rossi, P.; Le Donne, M.; Caruso, A.; Mancuso, S. 1992: Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. a cross-over study Journal of Reproductive Medicine 37(10): 834-840
Ivanovski, M.; Damcevski, N.; Radevska, B.; Doicev, G. 2012: Assessment of uterine artery and arcuate artery blood flow by transvaginal color Doppler ultrasound on the day of human chorionic gonadotropin administration as predictors of pregnancy in an in vitro fertilization program Akusherstvo i Ginekologiia 51(2): 55-60
Khonelidze, N.; Tsagareishvili, G.; Koiava, M.; Osidze, K. 2005: The use of gonadotropin-releasing hormone agonist (GnRH-a) dipherelin 3,75 mg for in vitro fertilization program Georgian Medical News 2005(121): 19-22
Andersen, A.N. 1977: Bromocriptine (Parlodel). a prolactin inhibiting dopamine receptor agonist Ugeskrift for Laeger 139(22): 1311-1313
March, C.M. 1978: Therapeutic regimens and monitoring techniques for human menopausal gonadotropin administration Journal of Reproductive Medicine 21(3 Suppl): 198-204
Reuter, K.L.; Cohen, S.; Furey, L.; Baker, S. 1996: Sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gonadotropin Journal of Reproductive Medicine 41(7): 509-514
Lin, J.; Ye, B.; Zhao, J.; Zhou, Y.; Huang, X.; Zheng, J. 2002: Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection Zhonghua Fu Chan Ke Za Zhi 37(10): 601-603
Buvat, J.; Marcolin, G.; Guittard, C.; Dehaene, J.L.; Verbecq, P.; Renouard, O.; Herbaut, J.C.; Louvet, A.L. 1989: Chorionic gonadotropin support of the luteal phase following in vitro fertilization and embryo transfer. Randomized comparison with oral progesterone in protocols using triptoreline Presse Medicale 18(10): 539
Zbella, E.A.; Vermesh, M.; Deppe, G.; Friberg, J. 1984: Coexistent complete hydatidiform mole and fetus after therapy with human menopausal gonadotropin. A case report Journal of Reproductive Medicine 29(10): 760-762
Check, J.H.; Adelson, H.G. 1984: Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring Obstetrics and Gynecology 63(2): 179-181
Edwards, R.G.; Bavister, B.D.; Steptoe, P.C. 1969: Early stages of fertilization in vitro of human oocytes matured in vitro Nature 221(5181): 632-635
Rossmanith, W.G.; Sterzik, K.; Wolf, A.S. 1987: Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease International Journal of Fertility 32(6): 460-466
Mack, R.B. 1988: Mairzy doats and dozy doats and a kiddle eat almost anything. Bromocriptine (Parlodel) overdose North Carolina Medical Journal 49(1): 17-18
Paszko, Z.; Padzik, H. 1970: An attempt to eliminate a high luteinizing hormone content from pituitary gonadotropin preparation of human menopausal urine origin and a further study of chorionic concentration Endokrynologia Polska 21(2): 211-218
Junca, A.M.; Plachot, M.; Mandelbaum, J. 1983: Evaluation of human sperm fertility by interspecific (human spermatozoa-hamster oocytes) in vitro fertilization Acta Europaea Fertilitatis 14(3): 191-196
Liu, K.E.; Alhajri, M.; Greenblatt, E. 2011: A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles Fertility and Sterility 96(3): 605-608